Trading resumes in Chelsea Therapeutics, up ~35% AH

|About: Chelsea Therapeutics Intern... (CHTP)|By:, SA News Editor

Chelsea Therapeutics (CHTP) resumes trading after being halted following the FDA's approval of Northera; shares now +35.5% after trading 33%-40% higher since restarting at 5:25.